an hour agoEU is accelerating distribution of vaccines to member states due to Omitron
Periskopi(4 years ago)
(4 years ago)The European Commission announced today that it had signed an agreement with Pfizer/ BioNtech to offer 20 million additional doses of vaccine against CO VID-19 in member states in the first half of 2022 to facilitate vaccine campaigns. The commission also reported that it had activated the first <x0 option to order more than 200 million doses, according to [...]
The European Commission announced today that it had signed an agreement with Pfizer/ BioNtech to offer 20 million additional doses of vaccine against CO VID-19 in member states in the first half of 2022 to facilitate vaccine campaigns.
The commission also reported that it had activated the first <x0 option to order more than 200 million doses under a third contract with Pfizer/ BioNTech”
“The Order also covers appropriate vaccines for the omicron variant, if such a vaccine becomes available” in the foreseeable future”, the Commission said in a statement, adding that remittances should begin in the second quarter 2022.
In the first quarter 2022, Pfizer/ BioNtech will provide 20 million additional vaccines (5 million in January, 5 million in February and 10 million in March).
These doses are added to 195 million doses already planned by Pfizer/ BioNTech, meaning that the total number of remittances in the first quarter would be 215 million, a European Commission statement said.
An agreement has also been reached with the pharmaceutical company Moderna for the delivery of additional vaccine doses during the first quarter of 2022.
This will be especially useful for member states with a short-term need for additional doses of the vaccine,” the Commission explained.
“Enhancing vaccine for all citizens and applying additional reinforcement doses are essential and urgent, the heads of EU states and governments said Thursday after a summit in Brussels.
“given the expected rapid increase in coronary infections, omitron, this movement is more urgent than ever, the commission said in a statement.
The European Commission, led by Ursula von der Leyen, reports that “will work closely with the vaccine producers to further speed up the distribution of doses in member countries and that inoculation for the first and the second time and strengthening doses may grow within weeks”.
The commission stresses that Omitron could become dominant in EU member states, where only 67% of the population has been fully vaccinated so far, by mid-January.
